慢性肝病
肝衰竭
医学
肝病
白细胞介素
免疫学
受体
内科学
内分泌学
细胞因子
肝硬化
作者
Katharina Maria Schwarzkopf,Larissa Eberle,Frank Erhard Uschner,Sabine Klein,Robert Schierwagen,Marcus Maximilian Mücke,Liliana Schaefer,Joan Clària,Stefan Zeuzem,Edith Hintermann,Urs Christen,Christian Markus Lange,Jonel Trebicka,Christoph Welsch
标识
DOI:10.1016/j.jhep.2020.05.012
摘要
Xiang et al. published interesting insights about the role of interleukin (IL)-22 in acute-on-chronic liver failure (ACLF).1 The authors elegantly analysed the effects of IL-22 in a mouse model of ACLF after chronic carbon tetrachloride (CCl4)-treatment (0.2 ml/kg, 2×/week, i.p.) and acute precipitating injury using 2 injections of 0.4 ml/kg CCl4 in combination with an i.p. challenge with Klebsiella pneumonia (K.P.), mimicking a bacterial infection. The model seems to induce a shift in the hepatic IL-22 signalling from the pro-regenerative IL-6/STAT3 towards the anti-regenerative IFNγ/STAT1 pathway paralleled by suppression of liver regeneration.
科研通智能强力驱动
Strongly Powered by AbleSci AI